Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01089309
Other study ID # WolfsonMC-2004-388
Secondary ID
Status Completed
Phase Phase 4
First received March 7, 2010
Last updated March 26, 2010
Start date May 2004
Est. completion date June 2007

Study information

Verified date March 2010
Source Wolfson Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

The present study investigated the long-term (12 months) effect of spironolactone treatment on glucose homeostasis, metabolic parameters and vascular properties.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date June 2007
Est. primary completion date June 2007
Accepts healthy volunteers No
Gender Both
Age group 45 Years to 85 Years
Eligibility Inclusion Criteria:

1. patients with type 2 diabetes mellitus

Exclusion Criteria:

1. history of unstable angina, myocardial infarction (MI), cerebrovascular accident (CVA)

2. major surgery within the six months preceding entrance to the study

3. unbalanced endocrine disease

4. any disease that might affect absorption of medications

5. plasma creatinine >2.5 mg/dl

6. elevation of liver enzymes to more that twice the upper normal limit

7. plasma potassium levels >5.5 mg/dl

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Spironolactone
Spironolactone orally, at a dose of 50 mg/day for 12 months

Locations

Country Name City State
Israel Wolfson Medical Center Holon

Sponsors (1)

Lead Sponsor Collaborator
Wolfson Medical Center

Country where clinical trial is conducted

Israel, 

See also
  Status Clinical Trial Phase
Recruiting NCT06133634 - Fisetin to Improve Vascular Function in Older Adults Phase 1/Phase 2
Completed NCT05872139 - Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging N/A
Recruiting NCT05095688 - Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
Recruiting NCT04558450 - Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN) N/A
Not yet recruiting NCT05943457 - Vitamin K2 Supplementation in Adult Episodic Migraine N/A
Not yet recruiting NCT04900610 - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis N/A
Completed NCT02226055 - An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka N/A
Completed NCT01559896 - Egg Protein Hydrolysate and Vascular Function N/A
Completed NCT04049162 - Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency N/A
Not yet recruiting NCT06440369 - Physical Activity and Cardiovascular Risk N/A
Completed NCT05537246 - The Relationship Between Arterial Stiffness and Hemodynamic Responses in Patients With Spinal Anesthesia
Completed NCT06151054 - Relationship Between Aortic Parietal Inflammation on 18F-FDG PET Scan and Arterial Stiffness as a Function of Age
Completed NCT02218268 - Arterial Stiffness in Type I Diabetes Mellitus N/A
Completed NCT00547040 - Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients
Completed NCT02821780 - CADASIL Disease Discovery
Completed NCT05719090 - Acute Effects of Autoregulated and Non-autoregulated Blood Flow Restrictive Exercise on Indices of Arterial Stiffness N/A
Completed NCT04549324 - Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Completed NCT05022498 - Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise N/A
Completed NCT03415880 - Light Intensity Physical Activity Trial N/A
Completed NCT03560804 - Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs N/A